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Management of postnatal depression
Charles Musters,1 Elizabeth McDonald,1 Ian Jones2
Depression is common in thepostpartumperiod. It can
be severe and may have serious consequences for the
woman and her child. The term postnatal depression,
however, is often applied indiscriminately to all
occurrences of psychological distress after childbirth.
It is important to identify and to treat postnatal
depression—recently published National Institute for
Health and Clinical Excellence (NICE) guidance
supports a range of effective psychological and
pharmacological interventions.1 Here, we discuss
current thinking on the clinical features, aetiology,
and management of postnatal depression.
What is postnatal depression?
Postnatal depression may form part of a bipolar or,
more usually, a unipolar illness. Estimates vary but the
overall prevalence of clinically relevant postnatal
depression is 13%.2 Although classification systems
consider onset within four weeks (Diagnostic and
Statistical Manual of Mental Disorders) or six weeks
(ICD-10; international classification of diseases, 10th
revision) to be “postpartum,” onsets within six months
or even longer are usually included in clinical practice.
Because several of the diagnostic features (box 1)—
such as tiredness, disturbed sleep, and reduced libido—
are common perinatally, other symptoms—particu-
larly feelings of worthlessness and hopelessness and
early morning wakening before the baby—need to be
sought. Suicidal thoughts and thoughts of harming the
baby should specifically be asked about.
What are the differential diagnoses?
The main differential diagnoses are postpartum blues
and postpartum psychosis. The blues affects at least
30% of women4; it causes transient emotional lability
during the firstweekafterbirthandhasawidevarietyof
symptoms typical of low and high mood.5 Care of the
baby is not impaired, hopelessness and worthlessness
are not prominent, andwomendo not feel suicidal. It is
self limiting, but assessment should ensure that the
woman is not and does not become more depressed.
The most severe form of postpartummood disorder
is puerperal (postpartum) psychosis. This condition is
not easy to define, but the core feature is the acute onset
of a manic or depressive psychosis soon after birth.6
This illness is a psychiatric emergency—patients are
usually admitted and treated, preferably in a mother
and baby unit.1 It occurs after around one in 1000
deliveries, but the risk is higher—in excess of one in two
deliveries—inwomenwith ahistoryofbipolar disorder
or puerperal psychosis.7 The tendency for all post-
partum episodes to be labelled as postnatal depression
can therefore have serious implications. The 2000-2
Confidential Enquiry into Maternal Deaths high-
lighted several suicides where previous postpartum
psychosis was recorded at booking as postnatal
depression, with suboptimal care being provided as a
result.8
Is childbirth a specific trigger for episodes of
depression?
The psychosocial upheaval of childbirth and new
motherhood is a potential risk factor for developing
depression—a “non-specific trigger”—just one in a
range of potential precipitants. However, a recent
study in sisters with recurrent unipolar depression
showed familial clusteringof vulnerability, particularly
for episodes with an onset within twomonths of birth.9
This suggests that childbirth may be a more specific
“puerperal trigger” in a subgroup of women (box 2).
The nature of the puerperal trigger is still unknown,
but several psychological, social, and biological factors
probably play a part. Genetic factors have been
implicated,9 and although most new mothers experi-
ence sleep deprivation, those who are most affected
maybeathigher risk.12Manystudieshave lookedat the
role of hormones, but have found nomajor differencesPostpartum blues or postnatal depression?
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in the hormonal physiology of women who develop
postnatal depression. However a small double blind
experimental study simulated the hormonal changes of
pregnancy and the puerperium in parous women with
and without a history of major depression and
precipitated depressive symptoms only in women
with a history of postnatal depression.13 This suggests
that women who become depressed immediately
postpartum may have an abnormal sensitivity to the
normal physiological changes of childbirth.
Who is at risk of postnatal depression?
Key meta-analyses published in the past decade
conclude that the principal risk factors for postnatal
depression are depression or anxiety during preg-
nancy; a history of depression; a history of other
psychiatric conditions; recent stressful life events; and
poor social support, particularly the lack of a suppor-
tive partner.14 15 The first of these risk factors highlights
the importance of assessing and treating antenatal
depression, and the possibility that a focus on postnatal
illness may draw attention away from illness in
pregnancy.
Although guidelines do not recommend routine
screening to identify women at risk of postnatal
depression,womenathigh riskofmore severeepisodes
of postpartum mood disorder, including puerperal
psychosis, should be identified.1 At booking or during
pregnancy specific information should be sought, such
aswhether thewomanhas previously been treated by a
psychiatrist; whether she has past or present severe
mental illness including schizophrenia, bipolar dis-
order, psychosis in the postnatal period, and severe
depression; and whether there is a family history of
perinatal mental illness.
Can postnatal depression be prevented?
Studies of prophylactic drugs or psychological inter-
ventions do not support routine non-targeted inter-
ventions to reduce postpartum depression; however,
intensive professional postpartum support individually
targeted at at-risk mothers may be beneficial.116 Two
small randomised clinical trials have examined anti-
depressantprophylaxis inpregnantwomenwithahistory
ofpostnataldepression.Atricyclicantidepressantwasnot
effective,17 but a selective serotonin reuptake inhibitor,
sertraline, started after delivery reduced the risk of
recurrence.18Although theevidencebase is scarce, itmay
be appropriate to offer antidepressant prophylaxis to
some women with a strong history of depression.
Women on long term antidepressants who stopped
treatment during pregnancy had a significantly increased
risk of depressive relapse—68% compared with 26% in
women who continued their drugs.19 However, the
women in this naturalistic study had longstanding and
severe unipolar depression, so these figuresmay not hold
for women with less severe forms of illness. Clearly, the
risks and benefits of continuing drugs during pregnancy,
evenwhenapreviousdepressiveepisodehasbeen treated
successfully,needcarefuldiscussionwithaffectedwomen.
For women with subthreshold depression, NICE
guidelines recommend providing social support and
brief structured psychotherapy (cognitive behavioural
Box 1 Summary of ICD-10 diagnostic criteria for
depression3
At least four, six, or eight symptoms are required for at
least twoweeks tomakeadiagnosis ofmild,moderate, or
severe depression, respectively. For mild and moderate
depression, at least two group A symptoms must be
present and for severe depression all three group A
symptoms are required.
Group A symptoms
Depressed mood to a degree that is abnormal for the
person, present for most of the day, largely uninfluenced
by circumstances
Loss of interest or pleasure in activities that are normally
pleasurable
Decreased energy or increased fatiguability
Group B symptoms
Loss of confidence or self esteem
Unreasonable feelings of self reproach or excessive and
inappropriate guilt
Recurrent thoughts of death or suicide, or any suicidal
behaviour
Complaints or evidence of reduced ability to think or
concentrate, such as indecisiveness
Change in psychomotor activity, with agitation or
retardation
Sleep disturbance of any type
Change in appetite (decrease or increase) with
corresponding weight change
Box 2 Is postnatal depression distinct fromnon-postpartumdepression?
There has long beendebate aboutwhether postnatal depression is a distinct clinical entity.
This debatehas focusedonwhether the condition is clinically distinct fromnon-postpartum
depression and whether depression is more prevalent after childbirth than at other times.
Little evidence exists to suggest that the clinical features of postnatal depression are very
different from depressive illness at other times of life.10 Several controlled studies over the
past 15 years have not found an increased incidence of depression after childbirth.
However, recent work suggests that women having children have fewer risk factors for
depression; if this is taken into account, the postpartum period may indeed be a time of
higher risk.11 The evidence does not therefore support postnatal depression as a separate
clinical entity, but itdoessupport thespecific triggeringofmooddisordersbychildbirth inat
least a proportion of women.
Box 3 TheWhooley questions20
 During the past month have you often been bothered
by feeling down, depressed, or hopeless?
 During the past month have you often been bothered
by having little interest or pleasure in doing things?
If the answer to either of these questions is positive, a
third question is recommended by NICE
 Is this something you feel you need or want helpwith?
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therapy or interpersonal therapy), although these may
not be available in all contexts
How should I assess a womanwith suspected postnatal
depression?
Depression should routinely and opportunistically be
considered in all women in the perinatal period. The
NICE guidelines recommend the Whooley questions
as a screening tool (box 3),1 although they have not
been investigated in the postnatal population. The
Edinburgh postnatal depression scale is used more
often, however. It has been psychometrically tested
extensively in postpartumwomen and is used through-
out the world. All of these are tools for screening, not
diagnosis, and should be used only to identify women
who need further clinical assessment.
Suspected mild and moderate depression can be
assessed and managed in primary care. Women with
severe depression or those who do not respond to
treatmentmay need to be assessed by a psychiatrist, and
referral should be urgent if there is a risk of self harm or
harm to the child. Consider involving children and
young persons’ social services in such cases (box 4).
How should I treat postnatal depression?
NICE guidelines recommend a stepped care approach
to the treatment of postnatal depression—self help
strategies, non-directive counselling, brief cognitive
behavioural therapy, and interpersonal psychotherapy
are all recommended formild tomoderate depression.
Antidepressants are recommended only if the patient
declines psychological therapy, if it does not work, or if
the woman has a history of severe depression. Even for
severe depression, psychological treatment (cognitive
behavioural therapy or interpersonal psychotherapy)
is recommended as first line—antidepressants are
prescribed only if requested by the patient, or if the
response to psychological treatment is only partial.
The local availability of psychological therapies is an
important factor when determining which treatment to
offer, however, and waiting times can be lengthy. It is
vital to treat womenwith severe illness promptly, even if
drugs have to be used.
Evidence for non-pharmacological treatments
A recent Cochrane meta-analysis of 10 trials of
psychological and psychosocial interventions con-
cluded that peer support and non-directive counsel-
ling, cognitive behavioural therapy, psychodynamic
psychotherapy, and interpersonal therapy are all
effective in postnatal depression.21
Evidence for pharmacological treatments
Partly because of the ethical and practical problems of
conducting drug trials in the perinatal period evidence
on pharmacological management is limited. One trial
randomised 87 women with postnatal depression to
one of four groups—fluoxetine or placebo with either
one or six sessions of cognitive behavioural
counselling.22 All groups significantly improved, and
improvementwas significantly greater in the fluoxetine
group than in the placebo group; however in this trial
the refusal rate was high because many women did not
want to take drugs. There is no evidence to suggest that
treatments of benefit in non-postpartumdepression are
not also effective in postnatal depression.23
Antidepressants and breast feeding
In breastfeeding women the risk-benefit balance of
antidepressant drugs is altered,with a consequent shift in
emphasis towards psychological therapies. Treatment
will depend on the patient’s preference, previous
Box 4 Assessing risk in postnatal depression
A detailed mental state examination is a specialist
assessment, but any clinician can sensitively ask about
current symptoms of low mood; about ideas of
worthlessness and hopelessness about the future; and
aboutbiological symptomssuchassevere insomnia,poor
appetite, and weight loss
Short term risksareof self neglect andneglect of thebaby,
further deterioration in the depressive illness, and suicide
and infanticide
A preliminary assessment of the risks of suicide and
infanticide can bemade by asking about three key areas:
 The current mental state including thoughts of
suicide and of harming the baby
 Any history of attempted suicide or harm to the
baby
 Situational and environmental factors that might
increase or decrease risk
When discussing symptoms of low mood, sensitively
askingwhether thewomanfeels that life isnotworth living
and whether she has ever thought of harming her baby
enables theclinician toassess themostseriousaspectsof
risk. Our experience is that mothers do not take offence if
the context is right
Any psychotic symptoms substantially increase risk,
particularly delusions or hallucinations that relate to the
baby
The woman should be referred for a same day emergency
appointment so that a detailed risk assessment can be
carriedout if self harmorharmto thebabyareapossibility
Tips for non-specialists
Womenwith postnatal depressionmay have contact only
with non-specialists, so all health professionals who see
pregnant and postnatal women need to be able to screen
for the illness
TheWhooley questions can be used as a brief and simple
screening tool but have not been validated in this
population. The Edinburgh postnatal depression scale
and thehospital anxiety anddepression scale can alsobe
usedwithout special training and take about fiveminutes
to complete
Treatment can be effectively organised via primary care.
Referral to specialist mental health services is advised for
severe or high risk illness
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responses to treatment, localavailabilityofpsychological
therapies, and the severity of the illness and the risks
involved.
Certain antidepressants are considered safer than
others in breastfeeding women, but in general the long
term outcomes for exposed babies are unknown.
Although tricyclic antidepressants have been prescribed
for longer, most recent reproductive safety data, which
include thousands of exposures, have been for selective
serotonin reuptake inhibitors.Becauseof concernsabout
toxicity, tricyclics are prescribed less often than selective
serotonin reuptake inhibitors for postnatal depression.
In a pooled analysis of 57 trials measuring concen-
trations of antidepressants in infant serum during
breast feeding,24 fluoxetine and citalopram had the
highest concentrations, and nortriptyline, sertraline,
and paroxetine were undetectable. Because of lack of
data, newer antidepressants, such as mirtazapine and
venlafaxine, are not recommended for breastfeeding
mothers.
Adverse effects may be greater in very young,
premature, or systemically unwell babies. As with all
drugs taken while breast feeding, the infant should be
monitored regularly for sedation; irritability; and
changes to sleep, feeding, and growth. New data are
emerging regularly and up to date advice from
specialist services may be useful in individual cases.
What are the outcomes of postnatal depression?
Unfortunately, differing definitions of postnatal
depression across studies make it difficult to interpret
the literature.Outcomes forwomenwithvery severeor
psychotic episodes of depression are different from
those for women with mild, subclinical depressive
symptoms, and generalisations are not helpful.
Whatever the severity, however, most women who
receive appropriate treatment completely recover but
are at risk of further postpartum and non-postpartum
episodes. Some women are probably particularly
vulnerable to depression related to childbirth. In a
study of 55 primiparous women with postnatal
depression and 40 controls followed over five years,25
women whose postnatal depression was their first
episode of depression had a higher risk of subsequent
postnatal depression (41% v 18%) but a lower risk of
non-postnatal depression (38% v 62%). On average,
postnatal episodes lasted three to six months, but a
substantial minority remained depressed at one year.
Clinical experience indicates that when postnatal
depression has arisen in the context of clear psycho-
social adversity, and has been mild or moderate in
severity, the risk of subsequent depressive episodes
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QUESTIONS FOR FUTURE RESEARCHANDONGOING
RESEARCH
Little published evidence of the effectiveness of drug
treatments in women with postnatal depression is
available, and further research is needed in this area
Further work is needed to understand the triggering of
mood disorders by childbirth, including the genetic and
other determinants of vulnerability
Studies assessing whether effective treatment of
antenatal depression can reduce the risk of postnatal
depression are also needed
Results from two large randomised controlled trials in the
UK will shortly be available. The PONDER (psychological
interventions for postnatal depression) trial is assessing
the effectiveness and cost effectiveness of two
psychological interventions for postnatal depression
delivered by health visitors. The RESPOND (randomised
evaluation of antidepressants and support for women
with postnatal depression) trial is comparing the
effectiveness of antidepressants with counselling for
postnatal depression delivered by health visitors
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depends on the persistence of the adverse circum-
stances. If the adversity was discrete—such as the
breakdown of a relationship—and has been resolved,
then the risk of future postnatal depressionmay be low,
but will depend on a wide range of factors particular to
the woman. However, early onset depression (within
the first six to eight weeks), severe depression, and
depression with bipolar or psychotic symptoms may
indicate a more specific puerperal triggering, and the
risks of subsequent postpartum episodes may be
higher. Advice about future risk should therefore be
tailored to the individual woman.
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SUMMARY POINTS
Postnatal depression occurs after 13% of births
A previous history of postnatal depression or of any mental illness, poor social support, and
depression during the pregnancy all increase the risk of developing the illness
Postnatal depression needs to be identified and treated promptly and adequately because it
can result in a range of lasting adverse outcomes for mother and child
A range of psychological therapies is effective in treating postnatal depression
Drugs are also effective and some antidepressants are thought to be safer in breastfeeding
mothers than others
Drugs are recommended for women who decline psychological therapy, or for whom there
would be an unacceptable delay in providing non-pharmacological measures
What types of article does the BMJ consider?
We are delighted to receive articles for publication—from
doctors and others—on the clinical, scientific, social,
political, and economic factors affecting health. We give
priority to articles that will help doctors to make better
decisions. Please see our advice to authors at http://
resources.bmj.com/bmj/authors, and if you would like to
submit an article do so via our online editorial office at
http://submit.bmj.com.
All original research articles are submitted, althoughwe
may invite submission (without promising acceptance) if
we come across research being presented at conferences, if
we see it in abstract form, or if the authorsmake an inquiry
about the suitability of their work before submission.
We are also pleased to consider submitted articles for
sections which carry a mix of commissioned and
submitted articles—editorials, analysis, clinical review,
practice, fillers, and Career Focus. Please follow the
specific advice on each of these article types (see http://
resources.bmj.com/bmj/authors/types-of-article) before
submitting your article. Some types of article—news,
features, observations, head to head, views and reviews—
are commissioned by the editors.
CLINICAL REVIEW
BMJ | 16 AUGUST 2008 | VOLUME 337 403
